These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Other 2020-005762-34 A phase 2 clinical trial assessing the efficacy and safety of adding cladribine for treatment modifying course of seropositive myasthenia gravis not-yet-due
Completed, but no date Terminated 2022-000245-33 To evaluate the effect of low-dose naltrexone (LDN) on pain perception and quality of life in women Ocena wpływu niskich dawek Naltreksonu (LDN) na odczuwanie bólu i jakość życia kobiet z wulwodyn... bad-data